We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations Literature searches were conducted in MEDLINE (via PubMed) and EMBASE to identify studies published between January ...
Monoclonal antibodies (mAbs) have become the most growth-accelerated segment of the biopharmaceutical industry, with advanced molecular engineering and antibody humanization making it possible to ...
In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...
January 12, 2010 — Healthcare professionals treating patients with sirolimus (Rapamune, Wyeth) must consider the type of laboratory assay being used for therapeutic drug monitoring, according to the ...
Jun Qu, PhD, professor, Department of Pharmaceutical Sciences, has been awarded a four-year $982,617 U01 grant from the National Institutes of Health (NIH). The study, called “Robust Mass ...
Over the past 20 years, the fight against cancer has been prosecuted with increasing zeal by protein kinase inhibitors. More numerous, more sophisticated, and better targeted than ever, these ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced the initiation of a large-scale, multi-center prospective clinical study to validate its circulating tumor DNA ...
Precision medicine is driven by advances in omics technologies that facilitate identification of mutations and the presence or absence of certain molecular targets, which, in turn, enables streamlined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback